Multifunctional Cataract Surgery Assistive Instruments Used in Cataract Surgery
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Dec 24, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of new multifunctional tools designed to assist in cataract surgery. These tools combine the functions of two to three traditional surgical instruments, which helps reduce the number of tools doctors need to switch during surgery. This could lead to less trauma for patients and improve the overall efficiency of the surgery. The study aims to compare the safety and effectiveness of these new tools with the standard instruments currently used in cataract surgery.
To be eligible for this trial, participants should be diagnosed with cataracts and need surgery to treat them. However, individuals with certain conditions, such as active eye inflammation or other serious eye or health issues, will not be included in the study. Participants can expect to have their surgery with these new multifunctional devices, and their experiences will help researchers understand whether these tools are beneficial compared to traditional methods. The trial is not yet recruiting, so there is still time to learn more about it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Clinical diagnosis of cataract Patients need to undergo cataract surgery
- Exclusion Criteria:
- • - Active intraocular inflammation The intraocular pressure (IOP) was higher than 25 mmHg The endothelial cell count (ECC) was less than 1,200 cells/mm2 Combined with other eye diseases Combined with other serious systemic diseases
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported